Neurodevelopmental Outcomes After Extreme Prematurity Comparing Bevacizumab to Laser Surgery for Type 1 Retinopathy of Prematurity

Developmental Medicine and Child Neurology - United States
doi 10.1111/dmcn.71_14017
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Wiley

Related search

Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity

Pediatrics
Child HealthPediatricsPerinatology
2016English

Animal Model for Retinopathy of Prematurity Laser Surgery Training

Journal of Pediatric Ophthalmology and Strabismus
MedicineChild HealthOphthalmologyPediatricsPerinatology
2017English

Intravitreal Bevacizumab for Retinopathy of Prematurity in Infants Ineligible for Laser Therapy*

Turkish Journal of Medical Sciences
Medicine
2016English

Late Recurrence of Retinopathy of Prematurity After Treatment With Both Intravitreal Bevacizumab and Laser

Journal of AAPOS
Child HealthOphthalmologyPediatricsPerinatology
2014English

Comparison of Intravitreal Ranibizumab and Bevacizumab Treatment for Retinopathy of Prematurity

Arquivos Brasileiros de Oftalmologia
MedicineOphthalmology
2015English

Retinopathy of Prematurity

2020English

Retinopathy of Prematurity

1998English

Retinopathy of Prematurity

Essentials in Ophthalmology
2016English

Diode Laser Treatment of Posterior Retinopathy of Prematurity

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy